Streetbeat News

Equity Actions

SPY

U.S. Treasury Secretary Janet Yellen has indicated that tax fairness will be a key component of President Joe Biden's second-term agenda. This includes ensuring that wealthy individuals and corporations pay more in taxes, while maintaining the tax cuts implemented during the Trump era for those earning less than $400,000 annually.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 6:35 pm

COLB

Seven analysts have recently provided their opinions on Columbia Banking System (NASDAQ:COLB), with sentiments ranging from bullish to bearish. Over the past three months, there have been 2 somewhat bullish and 5 indifferent ratings, with no bullish or bearish ratings. The 12-month price targets show an average of $25.14, down from the previous $31.50. Analysts from firms like RBC Capital, DA Davidson, and others have adjusted their ratings and price targets, generally lowering them. Columbia Banking System is a bank holding company with a subsidiary, Columbia State Bank, offering a range of banking services. The company has shown a revenue growth of 65.54% as of September 30, 2023, a net margin of 25.88%, an ROE of 2.87%, and an ROA of 0.26%, but has a high debt-to-equity ratio of 0.98.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 6:01 pm

KVUE

Kenvue Inc. (NYSE:KVUE) saw a slight increase in its stock price to $20.63, but experienced declines over the past month and year. Its P/E ratio of 35.92 is below the industry average, which could suggest undervaluation or weaker growth prospects. Investors should consider multiple factors beyond the P/E ratio when evaluating the company.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:15 pm

TSM

On CNBC, Steve Weiss revealed that he has increased his investment in Taiwan Semiconductor Manufacturing Company (TSMC).

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:12 pm

ADT

ADT Inc's stock is soaring after announcing the exit from its residential solar business and revealing shareholder appreciation initiatives. The solar segment reported an Adjusted EBITDA loss of $(89) million in nine months of FY23. The Board approved the divestiture of the solar business and is assessing the net costs of the exit. Additionally, ADT raised its quarterly dividend by 57% to $0.055 and authorized a $350 million share buyback program. The company also repaid $500 million of debt, reducing total debt by $2 billion. ADT will report Q4 and full-year results on February 28, 2024, and its shares are currently up 11.08% at $6.86.

Portfolio Pulse from Lekha Gupta

January 25, 2024 | 5:08 pm

AMD

NVDA

On CNBC, Bill Baruch revealed that he has trimmed his positions in NVIDIA and Advanced Micro Devices, indicating a potential change in his investment strategy or outlook on these companies.

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:04 pm

AMD

On CNBC, Josh Brown, a well-known financial analyst, announced that he has sold his position in Advanced Micro Devices (AMD).

Portfolio Pulse from Benzinga Newsdesk

January 25, 2024 | 5:03 pm

BOKF

In the last three months, 4 analysts have provided ratings on BOK Financial (NASDAQ:BOKF), all maintaining an 'Indifferent' stance. The average 12-month price target is $90.75, with a high of $98.00 and a low of $78.00. The current average target has decreased by 1.71% from the previous $92.33. BOK Financial's financial performance shows a -1.28% decline in revenue growth, a high net margin of 27.27%, an ROE of 2.76%, and an ROA of 0.27%, but a concerning debt-to-equity ratio of 1.31.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:01 pm

ELV

Elevance Health (NYSE:ELV) has received mixed analyst ratings over the past three months, with 4 somewhat bullish ratings. The average 12-month price target is $555.00, with a high of $574.00 and a low of $547.00, reflecting a 2.72% decrease from the previous average. Analysts from RBC Capital, Cantor Fitzgerald, and JP Morgan have provided updates, with actions ranging from maintaining to raising and lowering ratings and price targets. Elevance Health is a major health insurer in the U.S. with significant market capitalization, revenue growth, and financial performance indicators such as net margin, ROE, and ROA, but carries a higher debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:01 pm

SLM

SLM Corp (NASDAQ:SLM) has been analyzed by 9 analysts, showing diverse opinions with an average 12-month price target of $20.28, up 16.55% from the previous $17.40. Recent actions by analysts include raised price targets and ratings, indicating a positive outlook. Despite this, SLM faces financial challenges with a -12.0% revenue decline, below-average net margin, ROE, and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 25, 2024 | 5:01 pm